TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis Therapy
Data on tuberculosis therapy published by researchers at University of Paris
March 11th, 2008
New research, 'Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-alpha antagonist therapy: safe re-initiation of TNF-alpha blockers after appropriate anti-tuberculous treatment,' is the subject of a report. According to recent research from Paris, France, "This study investigated the long-term outcome of patients with tuberculosis (TB) as a complication of tumor necrosis factor (TNF)-alpha blocker therapy. All TB cases (n=21) complicating TNF-alpha blocker therapy from French university hospitals were collated between January 2000 and September 2002." "Outcome was assessed via a postal questionnaire during September...
Source: TB & Outbreaks Week (2008-03-11)
|
